Females are twice as likely to be diagnosed with Alzheimer's disease (AD) as males, but the underlying mechanisms of this sex difference are not well-understood. The motoric cognitive risk (MCR) syndrome is characterized by slow gait and subjective cognitive concerns and predicts both AD and vascular dementia (VaD). The prevalence of MCR is typically similar in females and males. We have previously shown that MCR is associated with cortical atrophy in frontal, parietal, and temporal regions.
Objective
The current study examined sex-specific, cortical (frontal), and subcortical (hippocampal) atrophy patterns associated with MCR.
Methods
Frontal cortical thicknesses (in 11 frontal regions) and hippocampal volumes (in 12 hippocampal subfields) were quantified in 940 females (M Age = 71.03 years) and 1108 males (M Age = 71.07 years). Sex-stratified linear models were used to examine frontal cortical thicknesses and hippocampal volumes as a function of MCR—after adjusting for age, education, total intracranial volume, study site, vascular comorbidities, white matter lesion burden, and multiple comparisons (with the false discovery rate).
Results
MCR-related frontal atrophy was observed (in pars orbitalis and caudal middle frontal) in males but not in females. MCR-related hippocampal atrophy (in CA1, molecular layer, GCMLDG, and Fimbria) was observed in females but not in males.
Conclusions
There are sex-specific patterns of atrophy associated with MCR. Females with MCR display brain atrophy patterns more consistent with early AD, while males with MCR display atrophy patterns more consistent with VaD.
NicholsESteinmetzJDVollsetSE, et al.Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health2022; 7: e105–e125.
AndrewsDDucharmeSChertkowH, et al.The higher benefit of lecanemab in males compared to females in CLARITY AD is probably due to a real sex effect. Alzheimers Dement2025; 21: e14467.
4.
Van DyckCHSwansonCJAisenP, et al.Lecanemab in early Alzheimer’s disease. N Engl J Med2023; 388: 9–21.
5.
MielkeMMVemuriPRoccaWA. Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol2014; 6: 37–48.
6.
MielkeMMAggarwalNTVila-CastelarC, et al.Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective. Alzheimers Dement2022; 18: 2707–2724.
7.
ZhangBLinLWuS, et al.Multiple subtypes of Alzheimer's disease base on brain atrophy pattern. Brain Sci2021; 11: 278.
8.
WangDHonnoratNToledoJB, et al.Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer's, vascular and Lewy body dementias. Brain2025; 148: 1963–1977.
9.
ByunMSKimSEParkJ, et al.Heterogeneity of regional brain atrophy patterns associated with distinct progression rates in Alzheimer’s disease. PLoS One2015; 10: e0142756.
10.
WhitwellJL. Progression of atrophy in Alzheimer's disease and related disorders. Neurotox Res2010; 18: 339–346.
11.
VergheseJWangCLiptonRB, et al.Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci2013; 68: 412–418.
12.
VergheseJAnnweilerCAyersE, et al.Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology2014; 83: 718–726.
JangHKwonHYangJ-J, et al.Correlations between gray matter and white matter degeneration in pure Alzheimer’s disease, pure subcortical vascular dementia, and mixed dementia. Sci Rep2017; 7: 9541.
15.
LogueMWPosnerHGreenRC, et al.Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients. Alzheimers Dement2011; 7: 493–500.
16.
FeinGDi SclafaniVTanabeJ, et al.Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology2000; 55: 1626–1635.
17.
AndersenKLaunerLJDeweyME, et al.Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group. Neurology1999; 53: 1992–1997.
18.
Jiménez-SánchezLHamiltonOKLClancyU, et al.Sex differences in cerebral small vessel disease: a systematic review and meta-analysis. Front Neurol2021; 12: 756887.
19.
PodcasyJLEppersonCN. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin Neurosci2016; 18: 437–446.
ChoiHIRyuCWKimS, et al.Changes in microvascular morphology in subcortical vascular dementia: a study of vessel size magnetic resonance imaging. Front Neurol2020; 11: 545450.
23.
DoiTVergheseJShimadaH, et al.Motoric cognitive risk syndrome: prevalence and risk factors in Japanese seniors. J Am Med Direct Assoc2015; 16: 1103.e21–5.
24.
IqbalKHasanainMAhmedJ, et al.Association of motoric cognitive risk syndrome with cardiovascular and noncardiovascular factors: a systematic review and meta-analysis. J Am Med Direct Assoc2022; 23: 810–822.
25.
MarquezIGarcia-CifuentesEVelandiaFR, et al.Motoric cognitive risk syndrome: prevalence and cognitive performance. a cross-sectional study. Lancet Reg Health Am2021; 8: 100162.
26.
JayakodyOBlumenHBreslinM, et al.Risk factors associated with the Motoric Cognitive Risk syndrome: a meta-analysis of data from a cross-national study. J Am Geriatr Soc2024; 72: 2656–2666.
27.
BeauchetOSekhonHBardenJ, et al.Association of motoric cognitive risk syndrome with cardiovascular disease and risk factors: results from an original study and meta-analysis. J Alzheimers Dis2018; 64: 875–887.
28.
BlumenHMAllaliGBeauchetO, et al.A gray matter volume covariance network associated with the motoric cognitive risk syndrome: a multicohort MRI study. J Gerontol A Biol Sci Med Sci2019; 74: 884–889.
29.
BlumenHMSchwartzEAllaliG, et al.Cortical thickness, volume, and surface area in the motoric cognitive risk syndrome. J Alzheimers Dis2021; 81: 651–665.
30.
NagamallaVVergheseJAyersE, et al.Distinct patterns of brain atrophy in amnestic mild cognitive impairment and motoric cognitive risk syndromes. Neurodegener Dis2024; 24: 117–128.
31.
ZhangJLiuYLanK, et al.Gray matter atrophy in amnestic mild cognitive impairment: a voxel-based meta-analysis. Front Aging Neurosci2021; 13: 627919.
32.
ZhangHSachdevPSWenW, et al.Gray matter atrophy patterns of mild cognitive impairment subtypes. J Neurol Sci2012; 315: 26–32.
33.
PetersenRCSmithGEWaringSC, et al.Mild cognitive impairment: clinical characterization and outcome. Arch Neurol1999; 56: 303–308.
34.
PetersenRCDoodyRKurzA, et al.Current concepts in mild cognitive impairment. Arch Neurol2001; 58: 1985–1992.
35.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med2004; 256: 183–194.
36.
BusseAHenselAGühneU, et al.Mild cognitive impairment. Neurology2006; 67: 2176–2185.
37.
HoltzerRMahoneyJVergheseJ. Intraindividual variability in executive functions but not speed of processing or conflict resolution predicts performance differences in gait speed in older adults. J Gerontol A Biol Sci Med Sci2014; 69: 980–986.
38.
BlumenHMHoltzerRBrownLL, et al.Behavioral and neural correlates of imagined walking and walking-while-talking in the elderly. Hum Brain Mapp2014; 35: 4090–4104.
39.
BeauchetOAllaliGAnnweilerC, et al.Association of motoric cognitive risk syndrome with brain volumes: results from the GAIT Study. J Gerontol A Biol Sci Med Sci2016; 71: 1081–1088.
40.
BeauchetOAllaliGLaunayC, et al.Gait variability at fast-pace walking speed: a biomarker of mild cognitive impairment?J Nutr Health Aging2013; 17: 235–239.
41.
GubbiSSchwartzECrandallJ, et al.Effect of exceptional parental longevity and lifestyle factors on prevalence of cardiovascular disease in offspring. Am J Cardiol2017; 120: 2170–2175.
42.
ZhangWBAleksicSGaoT, et al.Insulin-like growth factor-1 and IGF binding proteins predict all-cause mortality and morbidity in older adults. Cells2020; 9: 1368.
43.
CallisayaMLBeareRPhanTG, et al.Global and regional associations of smaller cerebral gray and white matter volumes with gait in older people. PLoS One2014; 9: e84909.
44.
SrikanthVPhanTGChenJ, et al.The location of white matter lesions and gait—A voxel-based study. Ann Neurol2010; 67: 265–269.
45.
SathyanSAyersEBlumenH, et al.Epidemiology of motoric cognitive risk syndrome in the Kerala Einstein Study: protocol for a prospective cohort study. JMIR Res Protoc2023; 12: e49933.
46.
VergheseJNooneMLJohnsonB, et al.Picture-based memory impairment screen for dementia. J Am Geriatr Soc2012; 60: 2116–2120.
47.
DoiTBlumenHMVergheseJ, et al.Gray matter volume and dual-task gait performance in mild cognitive impairment. Brain Imaging Behav2017; 11: 887–898.
48.
ShimadaHTsutsumimotoKLeeS, et al.Driving continuity in cognitively impaired older drivers. Geriatr Gerontol Int2016; 16: 508–514.
49.
GuzeSB. Diagnostic and statistical manual of mental disorders, (DSM-IV). Am J Psychiatry1995; 152: 1228–1228.
50.
YesavageJABrinkTLRoseTL, et al.Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res1982; 17: 37–49.
51.
BlumenHMJayakodyOAyersE, et al.Cognitive reserve proxies are associated with age-related cognitive decline - not age-related gait speed decline. Neurobiol Aging2024; 141: 46–54.
52.
JovicichJCzannerSGreveD, et al.Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage2006; 30: 436–443.
53.
JovicichJCzannerSHanX, et al.MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage2009; 46: 177–192.
54.
JovicichJMarizzoniMSala-LlonchR, et al.Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of cross-sectional and longitudinal segmentations. Neuroimage2013; 83: 472–484.
55.
FischlBvan der KouweADestrieuxC, et al.Automatically parcellating the human cerebral cortex. Cereb Cortex2004; 14: 11–22.
56.
DesikanRSSégonneFFischlB, et al.An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage2006; 31: 968–980.
57.
IglesiasJEAugustinackJCNguyenK, et al.A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI. Neuroimage2015; 115: 117–137.
58.
GlickmanMERaoSRSchultzMR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol2014; 67: 850–857.
59.
BenjaminiYHochbergY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol1995; 57: 289–300.
60.
EfronBTibshiraniR. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statist Sci1986; 1: 54–75.
61.
CorderEHSaundersAMStrittmatterWJ, et al.Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science1993; 261: 921–923.
62.
StrittmatterWJSaundersAMSchmechelD, et al.Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A1993; 90: 1977–1981.
63.
FarrerLACupplesLAHainesJL, et al.Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA1997; 278: 1349–1356.
64.
FleisherAGrundmanMJackCRJr., et al.Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol2005; 62: 953–957.
65.
MeinerZAyersEBennettDA, et al.Risk factors for the progression of motoric cognitive risk syndrome to dementia: retrospective cohort analysis of two populations. Eur J Neurol2021; 28: 1859–1867.
66.
SathyanSWangTAyersE, et al.Genetic basis of motoric cognitive risk syndrome in the Health and Retirement Study. Neurology2019; 92: e1427–e1434.
67.
OveisgharanSArvanitakisZYuL, et al.Sex differences in Alzheimer’s disease and common neuropathologies of aging. Acta Neuropathol2018; 136: 887–900.
68.
CoughlanGTKlingerHMBoyleR, et al.Sex differences in longitudinal tau-PET in preclinical Alzheimer disease: a meta-analysis. JAMA Neurol2025; 82: 364–375.
69.
BuckleyRFMorminoECRabinJS, et al.Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol2019; 76: 542–551.
70.
ChenP-HLinS-ILiaoY-Y, et al.Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: a pilot study using plasma Aβ42 and total tau. Front Aging Neurosci2022; 14: 981632.
71.
BommaritoGGaribottoVFrisoniGB, et al.The biological substrate of the motoric cognitive risk syndrome: a pilot study using amyloid-/tau-PET and MR imaging. J Alzheimers Dis2022; 87: 1483–1490.
72.
DoiTNakakuboSTsutsumimotoK, et al.The association of white matter hyperintensities with motoric cognitive risk syndrome. Cereb Circ Cogn Behav2022; 3: 100150.
73.
OltraJHabichASchwarzCG, et al.Sex differences in brain atrophy in dementia with Lewy bodies. Alzheimers Dement2024; 20: 1815–1826.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
